Behind the scenes, Aldevron has produced custom DNA to make millions of doses of vaccine to protect against the coronavirus. It is announcing expanded collaboration with Moderna, a leading manufacturer of a coronavirus vaccine that uses messenger RNA, also known as mRNA.
Agathos Biologics, a biotechnology startup in Fargo, is working to develop cell lines to develop vaccines and other drugs that are not derived from sources that pose ethical dilemmas, such as cells from aborted fetuses.
Biomed Protection has an online analytical tool to evaluate a vaccine's effectiveness against coronavirus mutations, which could help vaccine makers respond to the rapidly changing virus. The firm also is testing some of its own vaccine candidates that could be developed in North Dakota.
And here’s the governor’s tie-in to research and startups: “In the coming years, we’ll see dramatically better tools and solutions, thanks in part to biosciences research development and manufacturing that is happening right here in North Dakota.”
Fargo startup will use innovative technology to track coronavirus mutations and develop vaccine candidates that could start production here in December in partnership with Aldevron.
FARGO — Aldevron has announced a significant expansion of its ability to produce proteins and enzymes to meet the demands of the booming biotechnology and pharmaceutical industries.
FARGO -- In the beginning, Aldevron was two guys with a lot of time on their hands and an idea that was both simple and bold: They would do a lot of the tedious preparation work that would service biotechnology labs.
NDAWN or North Dakota Agricultural Weather Network is a popular tool with farmers and ranchers. North Dakota is known to have one of the best weather monitoring systems in the nation. AgweekTV gets an inside look at the sites around the region.Wa...
